Lipigesic

PuraMed BioScience®, Inc., (PMBS: OTCBB) announces that the reanalysis of the clinical trial results of its homeopathic formulation, LipiGesic® M, found that the migraine medication has “robust efficacy.” These results were  featured in the February 2013 issue of Headache: The Journal of Head and Face Pain, the official journal of the American Headache Society®. The [...]

SCHOFIELD, Wis., November 13, 2012/PRNewswire/ – PuraMed BioScience®, Inc,. (OTCQB: PMBS) announces that its homeopathic migraine formulation, LipiGesic® M, has been recognized as an excellent first-line therapy in the treatment for acute migraine. The declaration was made in the online article “Advances in Drug Development for Acute Migraine,” [page 14] scheduled for publication in an [...]

Bayer recently announced a new migraine formula; while the formulation may be new, the three ingredients are not. Aspirin, acetaminophen and caffeine are active ingredients that have been used by drug manufacturers in the past – including recalled Excedrin Migraine … and so migraine sufferers can expect similar pain relief results. Cause for concern While [...]

(Schofield WI – July 17, 2012)  –  PuraMed BioScience®, Inc., (OTCBB:PMBS) attended the National Association of Chain Drug Stores’ (NACDS) Marketplace 2012 held in Denver Colorado between June 23- 26 to complete the company’s key goals for the first half of 2012. “We have accomplished all the goals that we set for PuraMed BioScience during [...]

(Schofield WI – June 12, 2012)  –  PuraMed BioScience®, Inc., (OTCBB:PMBS) announced today that they will be attending NACDS’s tradeshow, Marketplace 2012, being held in Denver Colorado between June 23- 26, 2012. In conjunction with the event, PuraMed BioScience is implementing a media blitz for LipiGesic® M, which has been clinically tested by leading US [...]

SCHOFIELD, Wis., April 24, 2012 /PRNewswire/ – PuraMed BioScience, Inc. ® (OTC Bulletin Board: PMBS), the producer of over-the-counter medicinal and healthcare products, has implemented an aggressive public awareness campaign to promote LipiGesic M in the retail sector with major campaigns planned in May and June to promote sales at both Walgreens and CVS/pharmacy stores. [...]